USFDA has issued Form 483 with 10 observations for the Gundlamachnoor facility of Aurobindo Pharma.
The United States Food and Drug Administration (US FDA) inspected the Company Unit - IX, an intermediate facility situated at Gundlamachnoor Village, Sangareddy District, Telangana, from November 10 to November 18, 2022.
source https://www.pharmatutor.org/pharma-news/2022/aurobindo-pharma-facility-gets-form-483-with-10-observations
No comments:
Post a Comment